Targeted disruption of the MHC cell receptor
First Claim
Patent Images
1. An isolated cell in which expression of a beta 2microglobulin (B2M) gene is partially or fully inactivated by an insertion and/or deletion within GGCCTTA, TCAAAT, TCAAATT, TTACTGA and/or AATTGAA of exon 1 or exon 2 of the B2M gene.
3 Assignments
0 Petitions
Accused Products
Abstract
Disclosed herein are methods and compositions for inactivating MHC genes, using zinc finger nucleases (ZFNs) comprising a zinc finger protein and a cleavage domain or cleavage half-domain in conditions able to preserve cell viability. Polynucleotides encoding ZFNs, vectors comprising polynucleotides encoding ZFNs and cells comprising polynucleotides encoding ZFNs and/or cells comprising ZFNs are also provided.
-
Citations
8 Claims
- 1. An isolated cell in which expression of a beta 2microglobulin (B2M) gene is partially or fully inactivated by an insertion and/or deletion within GGCCTTA, TCAAAT, TCAAATT, TTACTGA and/or AATTGAA of exon 1 or exon 2 of the B2M gene.
Specification